In last trading session, Beta Bionics Inc (NASDAQ:BBNX) saw 0.36 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $10.96 trading at -$0.1 or -0.90% at ring of the bell on the day assigns it a market valuation of $475.12M. That closing price of BBNX’s stock is at a discount of -123.54% from its 52-week high price of $24.50 and is indicating a premium of 18.89% from its 52-week low price of $8.89. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.32 million shares which gives us an average trading volume of 596.10K if we extend that period to 3-months.
Beta Bionics Inc (NASDAQ:BBNX) trade information
Upright in the red during last session for losing -0.90%, in the last five days BBNX remained trading in the red while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $10.96 price level, adding 4.7% to its value on the day. Beta Bionics Inc’s shares saw a change of -53.62% in year-to-date performance and have moved -1.62% in past 5-day. Beta Bionics Inc (NASDAQ:BBNX) showed a performance of -16.65% in past 30-days. Number of shares sold short was 3.14 million shares which calculate 4.84 days to cover the short interests.
In 2025, company’s earnings growth rate is likely to be around 78.64% while estimates for its earnings growth in next 5 years are of 38.22%.
Beta Bionics Inc (NASDAQ:BBNX)’s Major holders
Insiders are in possession of 6.51% of company’s total shares while institution are holding 58.13 percent of that, with stock having share float percentage of 62.18%. Investors also watch the number of corporate investors in a company very closely, which is 58.13% institutions for Beta Bionics Inc that are currently holding shares of the company.
On the other hand, AB CAP FUND, INC.-AB Small Cap Growth Portfolio and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 571.29 shares of worth $6.26 million or 1.32% of the total outstanding shares. The later fund manager was in possession of 326.77 shares on Mar 31, 2025 , making its stake of worth around $3.58 million in the company or a holder of 0.75% of company’s stock.
